Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews.com
Research analysts at StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the stock. Tonix Pharmaceuticals Stock Performance Shares of Tonix Pharmaceuticals stock opened at $11.94 on Monday. The company’s 50 day moving average price […]
![Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews.com](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tonix-pharmaceuticals-holding-corp-logo-1200x675.png?v=20240610111324&w=240&h=240&zc=2)